Published in Women's Health Weekly, March 1st, 2007
The product is expected to be launched in Japan in April 2007 under the trade name Mirena 52mg and will significantly enhance the choice of methods of contraception available to women in Japan.
"In Japan there has been a limited choice in convenient, reliable, and reversible long-acting contraception," said Phil Smits, head of women's healthcare at Bayer Schering Pharma, AG. "We are delighted that with Mirena we can offer women in Japan an innovative long-acting method for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly